From: Quality of life of men treated with brachytherapies for prostate cancer
Treatment groups | Â | HDR | Â | Seed implantation | ||||
---|---|---|---|---|---|---|---|---|
 |  | R 2 | Beta | p |  | R 2 | Beta | p |
Measure | Predictor | Â | Â | Â | Predictor | Â | Â | Â |
SF36-physical function | Â | .48 | Â | Â | Â | .51 | Â | Â |
 | Age |  | -.39 | .09 | Income |  | .55 | .02 |
 | PSS |  | -.53 | .07 | EFC |  | -.42 | .10 |
 | PFC |  | -.54 | .10 |  |  |  |  |
 | EFC |  | .78 | .06 |  |  |  |  |
 | POSATT |  | .53 | .06 |  |  |  |  |
 | MAKDEC |  | -.49 | .07 |  |  |  |  |
SF36-physical role | Â | .50 | Â | Â | Â | .24 | Â | Â |
 | Sexual symptoms |  |  | .33 | .09 |  |  |  |
SF36-emotional role | Â | .48 | Â | Â | Â | .51 | Â | Â |
 | Age |  | -.39 | .09 | Income |  | .55 | .02 |
 | PSS |  | -.53 | .07 | EFC |  | -.42 | .10 |
 | PFC |  | -.54 | .10 |  |  |  |  |
 | EFC |  | .78 | .06 |  |  |  |  |
 | POSATT |  | .53 | .06 |  |  |  |  |
 | MAKDEC |  | -.49 | .07 |  |  |  |  |
SF36-bodily pain | Â | .48 | Â | Â | Â | .51 | Â | Â |
 | Age |  | -.39 | .09 | Income |  | .55 | .02 |
 | PSS |  | -.53 | .07 | EFC |  | -.42 | .10 |
 | PFC |  | -.54 | .10 |  |  |  |  |
 | EFC |  | .78 | .06 |  |  |  |  |
 | POSATT |  | .53 | .06 |  |  |  |  |
 | MAKDEC |  | -.49 | .07 |  |  |  |  |
SF36-general health | Â | .54 | Â | Â | Â | .34 | Â | Â |
 | PSS |  | -.58 | .04 | PFC |  | .52 | .10 |
 | Bowel symptoms |  | -.59 | .03 |  |  |  |  |
SF36-vitality | Â | .37 | Â | Â | Â | .36 | Â | Â |
SF36-social function | Â | .74 | Â | Â | Â | .71 | Â | Â |
 | Urinary symptoms |  | -.41 | .04 | Age |  | .43 | .02 |
SF36-mental health | Â | .71 | Â | Â | Â | .85 | Â | Â |
 | PSS |  | -.40 | .07 | Age |  | .26 | .05 |
 | Anxiety |  | -.5 | .05 | PSS |  | -.34 | .10 |
 |  |  |  |  | Anxiety |  | -.60 | .01 |
 |  |  |  |  |  | Urinary symptoms | -.28 | .05 |
 |  |  |  |  |  | Bowel symptoms | .39 | .03 |
 |  |  |  |  |  | Sexual symptoms | -.35 | .01 |
 |  |  |  |  |  | MAKDEC | .42 | .02 |